Study guide

Ocular hypertension, suspects and juvenile glaucoma

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Ocular hypertension, suspects and juvenile glaucoma

Key Takeaways Explain This Topic AI

OHT has raised pressure without demonstrated glaucomatous damage; a suspect may be defined by nerve or field uncertainty.

Interpret pressure, corneal thickness, optic nerve, fields and lifetime risk together.

The NICE 24 mmHg treatment pathway is a national recommendation, not a universal safe-pressure boundary.

Young patients with high pressure and damage need prompt evaluation for juvenile and secondary glaucoma.

Last updated: October 2026

Pressure is a risk factor, not the diagnosis

Ocular hypertension (OHT) means raised intraocular pressure (IOP) without demonstrated glaucomatous disc or field damage after appropriate assessment. A glaucoma suspect may instead have suspicious nerve appearance, a questionable field, strong family history or a relevant secondary mechanism. Juvenile open-angle glaucoma presents at a young age with an open angle and potentially severe pressure elevation. These categories require different decisions; treating every large cup as established glaucoma creates unnecessary lifelong medication, while dismissing high pressure in a young person risks decades of avoidable damage.

Confirm repeated Goldmann-type measurements, examine the angle, assess corneal thickness and inspect both optic nerves. Record acuity, refraction, pupils, stereoscopic disc appearance and baseline photographs or optical coherence tomography (OCT). Obtain reliable automated fields and repeat an unexpected defect. Review corticosteroid exposure, trauma, uveitis, pigment dispersion and pseudoexfoliation. A normal central field does not eliminate early structural disease, and an isolated red OCT sector does not prove glaucoma.

Estimating lifetime risk

The decision involves the probability of conversion, the likely speed of subsequent loss and the patient's remaining lifetime. Older age, higher pressure, thinner central cornea, larger vertical cup-to-disc ratio and worse field pattern standard deviation are recognized predictors in adult OHT cohorts. The Ocular Hypertension Treatment Study risk model concerns a defined adult population: it is not automatically calibrated for a child, a secondary glaucoma or an unusually high myopic disc. Family history and access to dependable surveillance also influence clinical judgement.

Corneal thickness is both a measurement-related consideration and an associated risk marker. Do not convert it into a universal number of mmHg to subtract. For example, a patient with pressures of 27 mmHg, a thin cornea and reproducible rim loss is not simply a low-risk OHT patient whose pressure can be mathematically corrected downward. Conversely, a thick cornea with an otherwise healthy nerve does not guarantee protection.

  • Assessment What changes the decision Common error
  • Pressure Repeated level, fluctuations, treatment exposure Diagnosing from one air-puff result
  • Nerve Rim loss, haemorrhage, longitudinal change Using cup size without disc size
  • Field Reproducible anatomically consistent deficit Treating one unreliable test as progression
  • Lifetime Age, comorbidity, expected rate, follow-up Applying the same target to every patient
  • Angle Open angle versus closure or secondary signs Omitting gonioscopy in a pressure referral
  • Observation and preventive treatment

Observation is active care: agree when pressure, disc imaging and fields will be repeated and what findings would trigger treatment. Explain that the patient may feel well despite developing glaucoma. Arrange earlier review for uncertainty, high pressure or unreliable access, rather than issuing an indefinite discharge based on one normal field.

The UK National Institute for Health and Care Excellence (NICE) recommends offering 360-degree selective laser trabeculoplasty to newly diagnosed OHT with IOP of at least 24 mmHg when there is a lifetime risk of visual impairment, excluding pigment-dispersion-associated cases from that recommendation. A prostaglandin analogue is an alternative when laser is declined, unsuitable, awaited or insufficient. This is a specific national pathway, not a definition that every European pressure below 24 mmHg is safe. European Glaucoma Society principles emphasize individualized risk and reassessment.

Treatment discussions include expected benefit, adverse effects, surface disease, adherence, costs and future options. Demonstrate drop instillation and check the patient can use the bottle. Document the untreated baseline before assigning a percentage reduction target. A medication-associated fall in pressure is not proof that the optic nerve will remain stable; longitudinal nerve and field assessment remains necessary.

Juvenile disease and family assessment

A teenager or young adult with markedly raised pressure, open angles and progressive cupping needs prompt specialist assessment. Distinguish juvenile open-angle disease from congenital glaucoma, anterior-segment dysgenesis, steroid response and trauma. Absence of infantile buphthalmos does not make severe juvenile disease benign. Ask about affected relatives and consider genetic counselling and appropriate testing, including MYOC in a compatible phenotype. A genetic result informs family evaluation; it does not replace examination or establish the severity in each relative.

Children may need adapted perimetry, imaging and sometimes examination under anaesthesia. Interpret pressure in the context of the anaesthetic and measurement conditions. Treatment must protect optic nerve function while supporting visual development. Drops require age-specific safety review, and refractory high pressure may need incisional surgery. Give the family a clear explanation of surveillance and the risk to the fellow eye.

Case reasoning

A 24-year-old has pressures of 36 and 34 mmHg, open angles, superior rim loss and repeatable inferior arcuate defects. Calling this OHT because the patient has no symptoms misses established damage. Identify juvenile open-angle glaucoma after excluding secondary causes, initiate pressure-lowering care, assess family history and plan a target appropriate to existing loss and long remaining lifetime. A different patient with healthy nerves, dependable normal fields and modest repeated elevation may reasonably be monitored after discussing individualized risk.

Sources: NICE NG81 recommendations and European Glaucoma Society guidelines .

Sections you finish are checked off in the contents.

  • Up Next
  • Lens-related glaucoma, aqueous misdirection and venous pressure
  • Continue learning